Abstract:AIM: To evaluate the influence of avidin chase on the side effects of radioimmunotherapy (RIT) in nude mice bearing human colon carcinoma and therapeutic outcome.METHODS: Purified anti-CEA monoclonal antibody (McAb) was biotinylated with NHS-biotin, and then radiolabeled with Re-188 by the direct method. Re-188-labeled biotinylated anti-CEA McAb (Re-188-CEA McAb-Bt) was intravenously injected followed by intravenous injection of avidin after 24 h. SPECT imaging and biodistribution study were performed at 28-48 h after the injection of Re-188-CEA McAb-Bt. Three groups of nude mice subcutaneously grafted with human colon carcinoma were treated 7 d after the graft. Mice in the avidin chase group received intravenous injection of Re-188-CEA McAb-Bt (11.1 MBq/20 mu g) followed by intravenous injection of cold avidin (80 mu g) after 24 h. Mice in the control group (treated group without avidin chase) only received the injection of Re-188-CEA McAb-Bt (11.1 MBq/20 mu g), another control group (non-treated group) only received 0.1 mL normal saline solution. Toxicity was evaluated on the basis of change of body weight and peripheral WBC counts, and therapy effects were determined by variation in tumor volume. Histological analysis of tumors was also performed.RESULTS: Avidin chase markedly accelerated the clearance of Re-188-CEA McAb-Bt from the blood and normal tissues. The tumor uptakes of Re-188-CEA McAb-Bt at 28 h were 5.90 and 6.42% ID/g, respectively, in chase group and in non-chase group, while the tumor-to-background (T/NT) ratios were 3.19 and 0.56, respectively. The tumor uptake was slightly decreased by avidin chase, but the T/NT ratios were increased. In treated groups the growth rate of body weight and the number of WBC decreased after injection of Re-188-CEA McAb-Bt, and the WBC counts recovered earlier in the group with avidin chase than in the group without avidin chase. Compared to the non-treated group, treated groups with and without avidin chase showed significant anti-tumor effects.CONCLUSION: Avidin chase can effectively reduce the side effects of RIT, and improve therapeutic efficacy. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Avidin Chase Reduces Side Effects of Radioimmunotherapy in Nude Mice Bearing Human Colon Carcinoma

Enhanced Tumor Inhibiting Effect of 131I-Bdi-1-based Radioimmunotherapy and Cytosine Deaminase Gene Therapy Modulated by a Radio-Sensitive Promoter in Nude Mice Bearing Bladder Cancer

Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.

Radioimmunotherapy of human colon cancer xenografts by using {sup 131}I labeled-CAb{sub 1} F(ab'){sub 2}

Observation of Therapeutical Effect of ~(188)Re-Anti-cea Momoclonal Antibody on Mice Colon Cancer Model

Radioimmunotherapy of Human Colon Cancer Xenografts with<sup>131</sup>I-Labeled Anti-CEA Monoclonal Antibody

Therapeutic Effect of 188Re-Mag3-depreotide on Non-Small Cell Lung Cancer in Vivo and in Vitro

Antitumor effect of 131 I-labeled anti-VEGFR2 targeted nanoparticles in anaplastic thyroid carcinoma mouse models

Re-188 Enhances The Inhibitory Effect Of Bevacizumab In Non-Small-Cell Lung Cancer

Radioimmunotherapy Of Human Colon Cancer Xenografts With I-131-Labeled Anti-Cea Monoclonal Antibody

The Biodistribution and Pretargeting Radioimmunoimaging of the Fusion Protein of Anti-Cea Single-Chain Antibody and Core-Streptavidin in Human Rectocolonic Tumor Bearing Nude Mice

Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody.

Inhibitory effect 131I-antiAFP McAb-DOX-BSA nanoparticles on hepatocellular carcinoma bearing nude mice

Local Radioimmunotherapy of Breast Cancer-Bearing Nude Mice Using Anti-Cea Monoclonal Antibody C50 Labeled with 131I

Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer

Fractionated Radioimmunotherapy Using Low Doses of Iodine-131 Labeled Anti-Cea Monoclonal Antibody after Tumor Volume Reduction.

Tumor Radioimmunoimaging of Chimeric Antibody in Nude Mice with Hepatoma Xenograft.

Radioimmunolocalization and blodistribution of 131Ⅰ labeled anti-CEA,TPS and mixture monoclonal antibody in nude mice bearing human breast cancer xenografts

Anti-oxidant Vitamins Reduce Normal Tissue Toxicity Induced by Radio-Immunotherapy.

[Influence of Combination of Low Dosage 131I-Labeled Anti-Carcinoembryonic Antigen Antibody C50 and 5-Fluorouracil on Tumor Growth of Colorectal Cancer Xenografts in Nude Mice].

Toxicity-reducing potential of extracorporeal affinity adsorption treatment in combination with the auristatin-conjugated monoclonal antibody BR96 in a syngeneic rat tumor model